How proteomics is transforming aging research
22 Sept 2026This infographic explores how proteomics is advancing the understanding of biological aging through large-scale protein analysis. Learn how the SomaScan™ Assay helps researchers investigate age-related changes in protein expression, identify organ-specific aging signatures and uncover biomarkers associated with disease risk. Discover how proteomic research has revealed distinct aging trajectories across organs, improved prediction of cognitive decline and cardiovascular risk, and enabled new approaches for studying aging biology and developing targeted therapeutics.
Resource details:
Resource type: Infographic
Page count: 1
Read time: 2 mins
Related products
Request Quote for All Products
SomaScan 11K Assay Services
SomaLogicThe SomaScan™ 11K Assay Services employ a highly multiplexed, sensitive, quantitative, and reproducible proteomic platform that profiles up to 11,000 human protein measurements in diverse sample types and species – without enrichment or depletion. Ideal for biomarker discovery, it supports basic, translational, pre-clinical, and clinical research across a wide range of diseases.
SomaScan 7K Assay Services
SomaLogicThe SomaScan Assay Services is a highly multiplexed, sensitive, quantitative, and reproducible protein profiling technology for discovering biomarkers in drug discovery, pre-clinical and clinical drug development across a wide range of diseases.
